-AFP was better than MDK in distinguishing HCC from non-HCC cases and HCV or HBV-associated HCC from liver cirrhosis.-MDK could distinguish NASH-related HCC from cirrhosis. -MDK was elevated 6 months prior to diagnosis in 67% of patients. This evidence concerns the gene MDK and metabolic dysfunction-associated steatohepatitis.